Literature DB >> 27988201

Early detection of Toxoplasma gondii infection by using a interferon gamma release assay: A review.

Shima Mahmoudi1, Setareh Mamishi2, Xun Suo3, Hossein Keshavarz4.   

Abstract

Antibody-based serological tests are currently the most common diagnostic methods for detection of Toxoplasma gondii; however, these tests bear several limitations. Recently, Interferon-gamma release assay (IGRA), a T-cell-based test, was introduced as an in vitro test for detection of T. gondii infection. Few studies have investigated the potential role of cell immunity in diagnosis of toxoplasmosis. IGRA accurately distinguished infected from uninfected individuals, showing strong lymphocyte activation after in vitro stimulation with T. gondii antigens, even during the first days of life. IGRA is an easy-operation and low-cost method to measure cell mediated immunity against T. gondii. The results of this review underline the importance of evaluating cellular immunity to establish an early diagnosis particularly for congenital toxoplasmosis. Therefore, ELISA-based IGRA holds the potential to become a useful diagnostic tool for early detection of T. gondii infection.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnostic method; Interferon-gamma release assay; Toxoplasma gondii

Mesh:

Substances:

Year:  2016        PMID: 27988201     DOI: 10.1016/j.exppara.2016.12.008

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  4 in total

1.  Specific antibody titer decay in neonates prenatally exposed to Toxoplasma gondii and their mothers.

Authors:  Serena Salomè; Claudia Grieco; Pasquale Fabio Barra; Eleonora Capone; Fiorentino Grasso; Francesca Carraturo; Pasquale Dolce; Paola Salvatore; Letizia Capasso; Francesco Raimondi
Journal:  Ital J Pediatr       Date:  2022-05-03       Impact factor: 3.288

Review 2.  Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays.

Authors:  Bettie Voordouw; Barry Rockx; Thomas Jaenisch; Pieter Fraaij; Philippe Mayaud; Ann Vossen; Marion Koopmans
Journal:  Clin Microbiol Rev       Date:  2019-12-11       Impact factor: 26.132

3.  Putative biomarkers for early diagnosis and prognosis of congenital ocular toxoplasmosis.

Authors:  Thádia Evelyn de Araújo; Luara Isabela Dos Santos; Angelica Oliveira Gomes; Ana Carolina Aguiar Vasconcelos Carneiro; Anderson Silva Machado; Jordana Grazziela Coelho-Dos-Reis; Vanessa Peruhype-Magalhães; Samantha Ribeiro Béla; Gláucia Manzan Queiroz Andrade; Daniel Vitor Vasconcelos-Santos; José Nélio Januário; Andréa Teixeira-Carvalho; Ricardo Wagner Almeida Vitor; Lis Ribeiro do Valle Antonelli; Eloisa Amália Vieira Ferro; Olindo Assis Martins-Filho
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379

4.  A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients.

Authors:  Linda Petrone; Elisa Petruccioli; Valentina Vanini; Gilda Cuzzi; Saeid Najafi Fard; Tonino Alonzi; Concetta Castilletti; Fabrizio Palmieri; Gina Gualano; Pietro Vittozzi; Emanuele Nicastri; Luciana Lepore; Andrea Antinori; Alessandra Vergori; Nadia Caccamo; Fabrizio Cantini; Enrico Girardi; Giuseppe Ippolito; Alba Grifoni; Delia Goletti
Journal:  Clin Microbiol Infect       Date:  2020-10-10       Impact factor: 8.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.